Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Argus Health
Harvard Business School
Deloitte
Express Scripts
Accenture
Cantor Fitzgerald
Citi
Covington

Generated: December 13, 2018

DrugPatentWatch Database Preview

VASOSTRICT Drug Profile

« Back to Dashboard

When do Vasostrict patents expire, and what generic alternatives are available?

Vasostrict is a drug marketed by Par Sterile Products and is included in one NDA. There are six patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in VASOSTRICT is vasopressin. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vasopressin profile page.

Drug patent expirations by year for VASOSTRICT
Generic Entry Opportunity Date for VASOSTRICT
Generic Entry Date for VASOSTRICT*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
SOLUTION;IV (INFUSION)

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for VASOSTRICT
11034-16-5
12678-42-1
196116-EP2272972A1
196116-EP2272973A1
196116-EP2277872A1
ADH (hormone)
AM012156
EINECS 234-236-2
HSDB 3412
Intertocin
Inyectable de vasopresina [INN-Spanish]
Pitressin (TN)
Pituitrin
Pituitrin P
SCHEMBL1172390
Solute injectable de vasopressine [INN-French]
Tonephin
UNII-Y87Y826H08
Vasopressin (JP17/USP)
Vasopressin, unspecified
Vasopressina
Vasopressina [DCIT]
Vasopressine
Vasopressini injectio [INN-Latin]
Vasopressins
Vasopressinum
Y87Y826H08

US Patents and Regulatory Information for VASOSTRICT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products VASOSTRICT vasopressin SOLUTION;IV (INFUSION) 204485-001 Apr 17, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Sterile Products VASOSTRICT vasopressin SOLUTION;IV (INFUSION) 204485-002 Dec 17, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Sterile Products VASOSTRICT vasopressin SOLUTION;IV (INFUSION) 204485-001 Apr 17, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for VASOSTRICT
Drugname Dosage Strength RLD Date
➤ Subscribe Injection 20 units/mL, 1 mL ➤ Subscribe ➤ Try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
US Army
Colorcon
Baxter
McKinsey
Deloitte
Moodys
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.